This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
CPPs can effectively deliver antidiabetic peptides like insulin and exendin-4 through the nasal route.
Why it matters
This research could lead to more effective treatments for diabetes and Alzheimer's disease by improving drug delivery methods. It highlights a non-invasive approach that could enhance patient compliance.
How the study worked
The review discusses various methodologies for enhancing the nasal delivery of macromolecular therapeutics, focusing on CPPs.
What this study cannot tell us
As a review, it does not present original experimental data and may not cover all recent advancements in the field.
Read the original research
Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides.
Frontiers in pharmacology, 13, 1068495
Citation
Maeng, Jeehye; Lee, Kyunglim. (2022). Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides.. Frontiers in pharmacology, 13, 1068495. https://doi.org/10.3389/fphar.2022.1068495